BSEInsider Trading / SAST3d ago · 17 Aug 2026, 02:25 pm
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Dhiren Chandulal Shah, Sunil Chinubhai Shah & PACs
Parmax Pharma Ltd · 540359
✦ AI SummaryPledge
Parmax Pharma Ltd has received a disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011, stating that Dhiren Chandulal Shah and Sunil Chinubhai Shah have acquired 11,52,450 equity shares of the company on August 13, 2026, pursuant to a Share Purchase Agreement dated June 08, 2026. This acquisition has increased their shareholding in the company to 58.01%.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern3/10
Regulatory Risk4/10
Balance Sheet Risk6/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Parmax Pharma Ltd - 540359 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Attachments (1)
📄pdf
Download →
5333DD26_DC54_4E69_B3C3_EF70AD0C0C06_142500.pdf
View document text
SU IL CHI UBHAI SHAH
Vidyabhavan, 22/39 New Jaganath Plot, Dr. Yagnik Road, Rajkot, Gujarat
BSE Limited
PhirozeJeejeebhoyTowers, Dalal Street,
Mumbai-400001, Maharashtra
TheCompanySecretary&ComplianceOfficer,
ParmaxPharmaLtd.
PlotNo.20,SurveyNo.52,
Rajkot-GondalNationalHighwayNo.27, Hadamtala, Tal.
Kotda Sangani,Rajkot-360311,India Gujarat
Scrip ID: PARMAX | Scrip Code: 540359
Dear Sir/Madam,
Sub: Disclosure under Regulation 29(2) of the Securities and Exchange Board of India (Substantial
Acquisition of Shares and Takeovers) Regulations, 2011, asamended ("SEBI (SAST) Regulations")
This is to inform you that, Dhiren Chandulal Shah (“Acquirer 1”) and Sunil Chinubhai Shah (“Acquirer 2”), Dhairya
Dhiren Shah (“PAC 1”), Hiren Pravin Doshi (“PAC 2”), Sheetal Hiren Doshi (“PAC 3”), Nirmal Sunilbhai Shah
(“PAC 4”), Vijaykumar Natvarlal Shiyani (“PAC 6”) and Kamlesh Natvarlal Shiyani (“PAC 7”), in terms of the SEBI
(SAST) Regulations, have acquired 11,52,450 equity shares of face value of Rs. 10.00 each of Parmax Pharma
Limited ("Target Company) on August 13, 2026 pursuant to the Share Purchase Agreement dated June 08, 2026.
This disclosure is being submitted in compliance with Regulation 29(2) of the SEBI (Substantial Acquisition of
Shares and Takeovers) Regulations, 2011.
You are requested to kindly take the same on record and acknowledge receipt of this disclosure.
Yourssiinncceerreellyy,,
Name:SUNIL SHAH
Acquirer 2
Place: Rajkot, Gujarat
Date: August 14, 2026
SU IL CHI UBHAI SHAH
Vidyabhavan, 22/39 New Jaganath Plot, Dr. Yagnik Road, Rajkot, Gujarat
Format for disclosures under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers)
Regulations, 2011
Parmax Pharma Limited
Name of the Target Company (TC)
Dhiren Chandulal Shah (“Acquirer 1”) and
Name(s) of the acquirer and Persons Acting in Concert
Sunil Chinubhai Shah (“Acquirer 2”)
(PAC) with the acquirer
Dhairya Dhiren Shah (“PAC 1”),
Hiren Pravin Doshi (“PAC 2”),
Sheetal Hiren Doshi (“PAC 3”),
Nirmal Sunilbhai Shah (“PAC 4”),
Rupa Sunil Shah (“PAC 5”),
Vijaykumar Natvarlal Shiyani (“PAC 6”),
Kamlesh Natvarlal Shiyani (“PAC 7”),
Abhay Chinubhai Shah (“PAC 8”),
Umang Alkesh Gosalia (“PAC 9”) and
Meena Alkesh Gosalia (“PAC 10”)
Whether the acquirer belongs to Promoter/Promoter group
BSE Limited (“BSE”)
Name(s) of the Stock Exchange(s) where the shares of TC
Scrip Code: 540359
are Listed
Number % w.r.t. total % w.r.t. total
share / voting diluted
Details of the acquisition / disposal as follows capital share/voting
wherever capital of the TC
applicable(*) (**)
Before the acquisition under consideration, holding
of :
a) Shares carrying voting rights
10,17,714 27.20% 27.20%
(Annexure A)
b) Shares in the nature of encumbrance (pledge/
- - -
lien/ non-disposal undertaking/ others)
c) Voting rights (VR) otherwise than by shares
- - -
d) Warrants/convertible securities/any other - - -
instrument that entitles the acquirer to receive
shares carrying voting rights in the T C (specify
holding in each category)
e) Total (a+b+c+d) 10,17,714 27.20% 27.20%
SU IL CHI UBHAI SHAH
Vidyabhavan, 22/39 New Jaganath Plot, Dr. Yagnik Road, Rajkot, Gujarat
Details of acquisition/sale
a) Shares carrying voting rights acquired/sold
11,52,450 30.81% 30.81%
(Annexure A)
b) VRs acquired /sold otherwise than by shares
- - -
c) Warrants/convertible securities/any other - - -
instrument that entitles the acquirer to receive
shares carrying voting rights in the TC (specify
holding in each category) acquired/sold
d) Shares encumbered / invoked/released by the - - -
acquirer
e) Total (a+b+c+/-d) 11,52,450 30.81% 30.81%
After the acquisition/sale, holding of:
21,70,164 58.01% 58.01%
a) Shares carrying voting rights
(Annexure A)
b) Shares encumbered with the acquirer
- - -
c) VRs otherwise than by shares - - -
d) Warrants/convertible securities/any other
instrument that entitles the acquirer to receive - - -
shares carrying voting rights in the TC (specify
holding in each category) after acquisition
e) Total (a+b+c+d)
21,70,164 58.01% 58.01%
Mode of acquisition / sale (e.g. open market / off-
Off market acquisition of equity shares pursuant to
market / public issue / rights issue / preferential
Share Purchase Agreement dated June 08, 2026
allotment / inter-se transfer etc).
August 13, 2026
Date of acquisition / sale of shares / VR or date of
receipt of intimation of allotment of shares, whichever
is applicable
!umber of Shares: 37,41,300
Equity share capital / total voting capital of the TC
Amount (in ₹): 3,74,13,000 (Face Value of ₹ 10/- per
before the said acquisition / sale
equity share)
!umber of Shares: 37,41,300
Equity share capital/ total voting capital of the TC
Amount (in ₹): 3,74,13,000 (Face Value of ₹ 10/-
after the said acquisition / sale
per equity share)
!umber of Shares: 37,41,300
Total diluted share/voting capital of the TC after
Amount (in ₹): 3,74,13,000 (Face Value of ₹ 10/- per
the said acquisition
equity share)
(*) Total share capital / voting capital to be taken as per the latest filing done by the company to the Stock
SU IL CHI UBHAI SHAH
Vidyabhavan, 22/39 New Jaganath Plot, Dr. Yagnik Road, Rajkot, Gujarat
Exchange under Clause 35 of the listing Agreement.
(**) Diluted share/voting capital means the total number of shares in the TC assuming full conversion of
the outstanding convertible securities/warrants into equity shares of the TC.
Signatureoftheacquirer/seller/AuthorisedSignatory
!ame:SUNIL SHAH
Acquirer 2
Place: Rajkot, Gujarat
Date: August 14, 2026
Enclosed:Annexure A
******
A!!EXURE -A
!ame of the Target Company: Parmax Pharma Limited
3741300
!ame(s) of the acquirer and
Acquirer/ Pre Post Percentage of
sr.no. Persons Acting in Concert Percentage
PAC Shareholding Shareholding Shareholding
(PAC) with the acquirer
1 DHIRE! CHA!DULAL SHAH Acquirer 1 0.00 0.00 467,238 12.49
2 SU!IL CHI!UBHAI SHAH Acquirer 2 0.00 0.00 71,077 1.90
3 DHAIRYA DHIRE! SHAH PAC 1 0.00 0.00 93,448 2.50
4 HIRE! PRAVI! DOSHI PAC 2 0.00 0.00 168,206 4.50
5 SHEETAL HIRE! DOSHI PAC 3 0.00 0.00 18,690 0.50
6 !IRMAL SU!ILBHAI SHAH PAC 4 32,500 0.87 124,597 3.33
7 RUPA SU!IL SHAH PAC 5 53,520 1.43 53,520 1.43
8 VIJAYKUMAR !ATVARLAL SHIYA!I PAC 6 0.00 0.00 124,597 3.33
9 KAMLESH !ATVARLAL SHIYA!I PAC 7 7,500 0.20 124,597 3.33
10 ABHAY CHI!UBHAI SHAH PAC 8 249394.00 6.67 249,394 6.67
11 UMA!G ALKESH GOSALIA PAC 9 200,000 5.35 200,000 5.35
12 MEE!A ALKESH GOSALIA PAC 10 474,800 12.69 474,800 12.69
TOTAL 1,017,714 27.20 2,170,164 58.01